Kenvue Inc

More Details of Kenvue Inc Company

Kenvue Inc. is a consumer health company. The Company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include Pain Care; Cough, Cold, and Allergy; and Other Self Care (Digestive Health; Smoking Cessation; Eye Care; and Other). The Skin Health and Beauty segment's product categories include face and body care and hair, sun, and others. The Essential Health segment's product categories include oral care, baby care and other essential health (women’s health, wound care, and other). Its differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, Band-Aid, Aveeno, Zyrtec, and Nicorette. The Company has a global footprint through which it sells and distributes its product portfolio in more than 165 countries across its four regions. The four region consists of North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).

Company Info

Company codeKVUE

Company nameKenvue Inc

IPO dateMay 04, 2023

Founded at2022

CEOMr. Thibaut Mongon

Number of employees22000

Security typeOrdinary Share

Fiscal year-endMay 04

Address1 Kenvue Way

CitySUMMIT

Stock exchangeNYSE Consolidated

CountryUnited States of America

Postal code07901

Phone19088741200

Websitehttps://www.kenvue.com

Company codeKVUE

IPO dateMay 04, 2023

Founded at2022

Company Executives

Name

Name/Position

Position

Shareholding

Change

Mr. Thibaut Mongon

Chief Executive Officer, Director

216.47K

+8.04%

Ms. Meredith (Meri) Stevens

Chief Operations Officer

64.44K

+5.82%

Mr. Carlton Lawson

Group President, Europe, Middle East and Africa and Latin America

56.32K

-14.66%

Mr. Paul Ruh

Chief Financial Officer

56.20K

+6.89%

Ms. Bing (Ellie) Xie

Group President, Asia Pacific

47.60K

+8.84%

Dr. Caroline Tillett

Chief Scientific Officer

44.13K

+6.62%

Mr. Jan Meurer

Group President, North America

33.18K

+15.35%

Ms. Luani Alvarado

Chief People Officer

31.36K

+9.72%

Ms. Charmaine England

Chief Growth Officer

29.06K

+5.68%

Mr. Michael E. Sneed

Independent Director

28.44K

+52.59%

Name

Name/Position

Position

Shareholding

Change

Mr. Thibaut Mongon

Chief Executive Officer, Director

216.47K

+8.04%

Ms. Meredith (Meri) Stevens

Chief Operations Officer

64.44K

+5.82%

Mr. Carlton Lawson

Group President, Europe, Middle East and Africa and Latin America

56.32K

-14.66%

Mr. Paul Ruh

Chief Financial Officer

56.20K

+6.89%

Ms. Bing (Ellie) Xie

Group President, Asia Pacific

47.60K

+8.84%

Dr. Caroline Tillett

Chief Scientific Officer

44.13K

+6.62%

Revenue Breakdown

Currency: USDUpdate time: Sun, Apr 6

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2021

FY2020

FY2019

By BusinessUSD

Name

Revenue

Proportion

Face and Body Care

2.94B

19.00%

Other Self Care

2.32B

15.00%

Cough, Cold and Allergy

2.16B

14.00%

Pain Care

2.01B

13.00%

Other Essential Health

1.70B

11.00%

Other

4.33B

28.00%

By RegionUSD

Name

Revenue

Proportion

Northern America

7.58B

49.04%

Europe, Middle East, and Africa

3.56B

23.03%

Asia - Pacific

2.97B

19.24%

Latin America

1.34B

8.69%

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Face and Body Care

2.94B

19.00%

Other Self Care

2.32B

15.00%

Cough, Cold and Allergy

2.16B

14.00%

Pain Care

2.01B

13.00%

Other Essential Health

1.70B

11.00%

Other

4.33B

28.00%

Shareholder

Update time: Fri, Feb 21

Shareholder Statistics

Type

Shareholder Statistics

Shareholder

Proportion

T. Rowe Price Associates, Inc.

12.62%

The Vanguard Group, Inc.

11.35%

State Street Global Advisors (US)

6.28%

Fidelity Management & Research Company LLC

5.53%

MFS Investment Management

4.89%

Other

59.34%

Shareholder Statistics

Shareholder

Proportion

T. Rowe Price Associates, Inc.

12.62%

The Vanguard Group, Inc.

11.35%

State Street Global Advisors (US)

6.28%

Fidelity Management & Research Company LLC

5.53%

MFS Investment Management

4.89%

Other

59.34%

Type

Shareholder

Proportion

Investment Advisor

47.13%

Investment Advisor/Hedge Fund

44.82%

Hedge Fund

3.00%

Research Firm

2.71%

Pension Fund

1.87%

Sovereign Wealth Fund

1.36%

Bank and Trust

1.18%

Family Office

0.19%

Family Office

0.19%

Institutional Shareholding

Update time: Sun, Jan 19

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q1

1954

1.96B

102.81%

-254.82M

2024Q4

1944

1.96B

102.60%

-253.31M

2024Q3

1828

1.91B

99.61%

-331.64M

2024Q2

1723

1.90B

99.19%

-79.08M

2024Q1

1598

1.90B

99.47%

-51.94M

2023Q4

1442

1.89B

98.66%

-22.82M

2023Q3

1206

1.90B

99.22%

-343.08M

2023Q2

232

1.95B

101.85%

+1.90B

2023Q1

1

--

0.00%

-14.23K

2022Q4

1

--

0.00%

-14.23K

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

T. Rowe Price Associates, Inc.

242.05M

12.66%

+8.03M

+3.43%

Dec 31, 2024

The Vanguard Group, Inc.

217.71M

11.39%

+1.67M

+0.77%

Dec 31, 2024

State Street Global Advisors (US)

120.40M

6.3%

-6.81M

-5.36%

Dec 31, 2024

Fidelity Management & Research Company LLC

106.19M

5.56%

-9.01M

-7.82%

Dec 31, 2024

MFS Investment Management

93.86M

4.91%

+10.11M

+12.07%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

93.06M

4.87%

+2.22M

+2.44%

Dec 31, 2024

Wellington Management Company, LLP

68.36M

3.58%

-10.72M

-13.56%

Dec 31, 2024

Geode Capital Management, L.L.C.

46.07M

2.41%

+1.39M

+3.12%

Dec 31, 2024

Harris Associates L.P.

31.52M

1.65%

+58.77K

+0.19%

Dec 31, 2024

Managed Account Advisors LLC

25.86M

1.35%

-11.13M

-30.10%

Dec 31, 2024

Related ETFs

Update time: Sun, Apr 6

Name

Proportion

Renaissance IPO ETF

9.45%

VanEck Morningstar Wide Moat Value ETF

4.62%

Cullen Enhanced Equity Income ETF

3.98%

TBG Dividend Focus ETF

3.63%

TrueShares Low Volatility Equity Income ETF

3.14%

First Trust US Equity Opportunities ETF

3.04%

Invesco S&P 500 Equal Weight Consumer Staples ETF

2.94%

ProShares Ultra Consumer Staples

2.63%

Consumer Staples Select Sector SPDR Fund

2.62%

iShares US Consumer Staples ETF

2.26%

Renaissance IPO ETF

Proportion9.45%

VanEck Morningstar Wide Moat Value ETF

Proportion4.62%

Cullen Enhanced Equity Income ETF

Proportion3.98%

TBG Dividend Focus ETF

Proportion3.63%

TrueShares Low Volatility Equity Income ETF

Proportion3.14%

First Trust US Equity Opportunities ETF

Proportion3.04%

Invesco S&P 500 Equal Weight Consumer Staples ETF

Proportion2.94%

ProShares Ultra Consumer Staples

Proportion2.63%

Consumer Staples Select Sector SPDR Fund

Proportion2.62%

iShares US Consumer Staples ETF

Proportion2.26%

Dividend

A total of 2.32B USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

Jan 16, 2025

KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Feb 26, 2025 going ex on Feb 12, 2025

Feb 12, 2025

Feb 26, 2025

Feb 12, 2025

Oct 17, 2024

KVUE.NB Final Cash Dividend of gross USD 0.205 paid on Nov 27, 2024 going ex on Nov 13, 2024

Nov 13, 2024

Nov 27, 2024

Nov 13, 2024

Jul 25, 2024

KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Aug 28, 2024 going ex on Aug 14, 2024

Aug 14, 2024

Aug 28, 2024

Aug 14, 2024

Apr 25, 2024

KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on May 22, 2024 going ex on May 07, 2024

May 08, 2024

May 22, 2024

May 07, 2024

Jan 25, 2024

KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Feb 28, 2024 going ex on Feb 13, 2024

Feb 14, 2024

Feb 28, 2024

Feb 13, 2024

Oct 26, 2023

KVUE.NB Final Cash Dividend of gross USD 0.2 paid on Nov 22, 2023 going ex on Nov 07, 2023

Nov 08, 2023

Nov 22, 2023

Nov 07, 2023

Jul 20, 2023

KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Sep 07, 2023 going ex on Aug 25, 2023

Aug 28, 2023

Sep 07, 2023

Aug 25, 2023

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

23.010USD

Kenvue Inc

23.010

Overview

Company